As companies celebrate expected savings from the U.S. tax overhaul, one industry is battling the reinstatement of what it sees an onerous levy: a 2.3% excise tax on sales of medical devices such as pacemakers and artificial knees.

The tax took force again on Jan. 1 after the expiration of a two-year suspension that was approved by Congress and signed by President Barack Obama in 2015. The tax was originally enacted with the Affordable Care Act in 2010 to help fund some of its provisions and medical-device makers paid it from... RELATED VIDEO Winners and Losers of the GOP Tax Bill Christmas may be over but WSJ’s Richard Rubin keeps the holiday spirit alive by explaining who’s getting presents and who’s getting coal with the GOP tax bill. To Read the Full Story Subscribe Sign In